FDA Clears Stryker's Mako Robot To Treat Total Hip Replacement
This article was originally published in The Gray Sheet
Executive Summary
Stryker advanced its robotic-assisted surgery opportunity with its 510(k) clearance to use its Mako system for total hip replacement surgeries. The large joint replacement manufacturer's long-term strategy is to make medical robotics that will be adopted by hospitals because their machines are compatible with different Stryker joints.
You may also be interested in...
Business Briefs: Knee, Obesity Approvals, And A Deal Roundup
Key approvals for Stryker and Apollo Endosurgery, and deals by Boston Scientific, Illumina, Abbott and Lombard Medical.
Ethicon Looks To Jumpstart Robotics Program With Google Partnership
The Johnson & Johnson division plans to work with the technology giant to create a robot-assisted minimally invasive surgery platform.
Stryker MAKO Purchase Could Preview Ortho’s Future
Market-leading orthopedic firms have mostly come up with incremental product updates in response to the growing tide of more technology-heavy upstarts. That is what makes Stryker’s $1.65 billion acquisition of MAKO Surgical stand out.